PRL and breast cancer: No association was found between duration of exposure to prolactin-sparing antipsychotics and breast cancer, neither for exposure of 1–<5 years (aOR = 1.17, 95% CI = 0.98–1.40) nor for ≥5 years (aOR = 0.99, 95% CI = 0.78–1.26).